Allergan Inc. Receives CEO Cancer Gold Standard(TM) Accreditation

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its employees and their families through screenings, early detection, and healthy changes in lifestyle and in the workplace.

MORE ON THIS TOPIC